Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney Disease
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.